Molecular analysis of the EGFR-RAS-RAF pathway in pancreatic ductal adenocarcinomas: lack of mutations in the BRAF and EGFR genes (Q30811836)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article

Language	Label	Description	Also known as
English	Molecular analysis of the EGFR-RAS-RAF pathway in pancreatic ductal adenocarcinomas: lack of mutations in the BRAF and EGFR genes	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

Molecular analysis of the EGFR-RAS-RAF pathway in pancreatic ductal adenocarcinomas: lack of mutations in the BRAF and EGFR genes (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

1 reference

based on heuristic

inferred from title

5

object named as

Anders Molven

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

author name string

Heike Immervoll

1

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

Dag Hoem

2

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

Kalaiarasy Kugarajh

3

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

Solrun J Steine

4

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

publication date

6 April 2006

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

Virchows Archiv

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

448

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

788-796

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

BRAF and FBXW7 (CDC4, FBW7, AGO, SEL10) mutations in distinct subsets of pancreatic cancer: potential therapeutic targets

1 reference

https://api.crossref.org/works/10.1007%2FS00428-006-0191-8

21 January 2018

Sensitive sequencing method for KRAS mutation detection by Pyrosequencing

1 reference

https://api.crossref.org/works/10.1007%2FS00428-006-0191-8

21 January 2018

Telomere shortening is nearly universal in pancreatic intraepithelial neoplasia

1 reference

https://api.crossref.org/works/10.1007%2FS00428-006-0191-8

21 January 2018

Detection of point mutation in K-ras oncogene at codon 12 in pancreatic diseases

1 reference

https://pubmed.ncbi.nlm.nih.gov/16598499

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/16598499

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Abrogation of the Rb/p16 tumor-suppressive pathway in virtually all pancreatic carcinomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/16598499

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term results of partial pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head: 25-year experience

1 reference

https://pubmed.ncbi.nlm.nih.gov/16598499

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Orthotopic transplantation models of pancreatic adenocarcinoma derived from cell lines and primary tumors and displaying varying metastatic activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/16598499

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Method of mutation analysis may contribute to discrepancies in reports of (V599E)BRAF mutation frequencies in melanocytic neoplasms

1 reference

https://pubmed.ncbi.nlm.nih.gov/16598499

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mutational activation of the RAS-RAF-MAPK and the Wnt pathway in small intestinal adenocarcinomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/16598499

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

BRAF mutations in papillary carcinomas of the thyroid

1 reference

https://pubmed.ncbi.nlm.nih.gov/16598499

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activated BRAF targets proximal colon tumors with mismatch repair deficiency and MLH1 inactivation

1 reference

https://pubmed.ncbi.nlm.nih.gov/16598499

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mutations of the BRAF gene in human cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/16598499

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization

1 reference

https://pubmed.ncbi.nlm.nih.gov/16598499

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cancer statistics, 2003.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16598499

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inherited predisposition to cancer: a historical overview.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16598499

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Somatic alterations in the human cancer genome

1 reference

https://pubmed.ncbi.nlm.nih.gov/16598499

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

BRAF and K-ras gene mutations in human pancreatic cancers.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16598499

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of K-ras point mutations at codon 12 and p21 expression in pancreatic cancer between Japanese and Chinese patients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16598499

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

K-ras oncogene subtype mutations are associated with survival but not expression of p53, p16(INK4A), p21(WAF-1), cyclin D1, erbB-2 and erbB-3 in resected pancreatic ductal adenocarcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/16598499

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

BRAF and KRAS mutations in colorectal hyperplastic polyps and serrated adenomas.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16598499

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epidemiology and prevention of pancreatic cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/16598499

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pancreatic cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/16598499

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/16598499

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mutations of BRAF and KRAS2 in the development of Barrett's adenocarcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/16598499

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

BRAF and NRAS Mutations Are Frequent in Nodular Melanoma but Are not Associated with Tumor Cell Proliferation or Patient Survival

1 reference

https://pubmed.ncbi.nlm.nih.gov/16598499

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Familial pancreatic cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/16598499

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Progression model for pancreatic cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16598499

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Defective DNA mismatch repair in long-term (> or =3 years) survivors with pancreatic cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/16598499

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/16598499

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

RAF/RAS oncogenes and mismatch-repair status

1 reference

https://pubmed.ncbi.nlm.nih.gov/16598499

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

1 reference

https://pubmed.ncbi.nlm.nih.gov/16598499

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Frequency of K-ras mutations in pancreatic intraductal neoplasias associated with pancreatic ductal adenocarcinoma and chronic pancreatitis: a meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/16598499

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The K-ras mutation pattern in pancreatic ductal adenocarcinoma usually is identical to that in associated normal, hyperplastic, and metaplastic ductal epithelium.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16598499

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pancreatic adenocarcinomas with DNA replication errors (RER+) are associated with wild-type K-ras and characteristic histopathology. Poor differentiation, a syncytial growth pattern, and pushing borders suggest RER+

1 reference

https://pubmed.ncbi.nlm.nih.gov/16598499

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High frequency of mutations of the PIK3CA gene in human cancers

1 reference

https://pubmed.ncbi.nlm.nih.gov/16598499

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor-suppressive pathways in pancreatic carcinoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16598499

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Kirsten ras mutations in patients with colorectal cancer: the 'RASCAL II' study

1 reference

https://pubmed.ncbi.nlm.nih.gov/16598499

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Colorectal cancer with mutation in BRAF, KRAS, and wild-type with respect to both oncogenes showing different patterns of DNA methylation

1 reference

https://pubmed.ncbi.nlm.nih.gov/16598499

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Genetic and clinical features of human pancreatic ductal adenocarcinomas with widespread microsatellite instability

1 reference

https://pubmed.ncbi.nlm.nih.gov/16598499

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Does anyone survive pancreatic ductal adenocarcinoma? A nationwide study re-evaluating the data of the Finnish Cancer Registry

1 reference

https://pubmed.ncbi.nlm.nih.gov/16598499

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mutational analysis of BRAF in gallbladder carcinomas in association with K-ras and p53 mutations and microsatellite instability.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16598499

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tracing origin of serrated adenomas with BRAF and KRAS mutations.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16598499

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A Two-Step Enriched-Nested PCR Technique Enhances Sensitivity for Detection of Codon 12 K-ras Mutations in Pancreatic Adenocarcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/16598499

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Overexpression of the epidermal growth factor receptor in human pancreatic cancer is associated with concomitant increases in the levels of epidermal growth factor and transforming growth factor alpha

1 reference

https://pubmed.ncbi.nlm.nih.gov/16598499

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ki-ras and p53 gene mutations in pancreatic ductal carcinoma: a relationship with tumor phenotype and survival

1 reference

https://pubmed.ncbi.nlm.nih.gov/16598499

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00428-006-0191-8

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30811836&oldid=2194991430"